Skip to main content

Patel Dinesh V PH D's Form 4 filing

Protagonist Therapeutics, Inc (PTGX) · filed Jan 27, 2026

Accession no.
0001104659-26-007129
Filed
Jan 27, 2026
Trade date
Jan 23-27, 2026
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 9 non-derivative transactions and 4 derivative transactions. Open-market sales total $4.06M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Patel Dinesh V PH DCIK 0001120477Director, Officer (President and CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 23, 2026Common StockGGiftDisposed−6,000$0.00$0574,505Direct
Jan 23, 2026Common StockMOption exerciseAcquired+19,315$4.21+$81,316.15593,820Direct
Jan 23, 2026Common StockSSaleDisposed−19,315$84.59−$1,633,855.85574,505Direct
Jan 26, 2026Common StockMOption exerciseAcquired+10,685$4.21+$44,983.85585,190Direct
Jan 26, 2026Common StockSSaleDisposed−10,685$84.00−$897,540574,505Direct
Jan 26, 2026Common StockMOption exerciseAcquired+14,205$21.58+$306,543.9588,710Direct
Jan 26, 2026Common StockSSaleDisposed−14,205$84.05−$1,193,930.25574,505Direct
Jan 27, 2026Common StockMOption exerciseAcquired+4,068$21.58+$87,787.44578,573Direct
Jan 27, 2026Common StockSSaleDisposed−4,068$83.19−$338,416.92574,505Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 23, 2026Common StockMOption exerciseDisposed−19,315$0.00$010,685Direct
Jan 26, 2026Common StockMOption exerciseDisposed−10,685$0.00$00Direct
Jan 26, 2026Common StockMOption exerciseDisposed−14,205$0.00$0304,068Direct
Jan 27, 2026Common StockMOption exerciseDisposed−4,068$0.00$0300,000Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)